BACE1 cleaves APP(18-770) to APP(18-671) and APP(672-770)

Stable Identifier
Reaction [transition]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Amyloid precursor protein (APP(18-770)) is processed by one of two distinct proteolytic pathways; the non-amyloidogenic pathway where alpha-secretase cleaves APP at the cell surface within the A-beta domain, liberating APPs-alpha and the amyloidogenic pathway, where beta-secretase followed by gamma-secretase cleavages results in peptides which are the main fibril-forming peptides implicated in Alzheimer's disease. In the first step of the amyloidogenic pathway, the endosomal membrane protein beta-secretase 1 (BACE1) catalyses the cleavage of APP(18-770) within the ectodomain and liberates a soluble proteolytic fragment, termed soluble APP-beta (APPs-beta, APP(18-671)) and C99 (APP(672-770) (Baranello et al. 2015, Andrew et al. 2016). APP processing can occur in several endocytic and secretory pathways. For simplicity, the endosome has been chosen in this event.

Literature References
PubMed ID Title Journal Year
25523424 Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease

Padmaraju, V, Lahiri, DK, Chopra, N, Sambamurti, K, Baranello, RJ, Pappolla, MA, Greig, NH, Bharani, KL

Curr Alzheimer Res 2015
Catalyst Activity

beta-aspartyl-peptidase activity of BACE1 [endosome membrane]

Cite Us!